Do calcimimetics directly alter bone remodeling?
Goltzman
David
D
D000818:Animals; D015415:Biomarkers / Q000097:blood; D016723:Bone Remodeling / Q000187:drug effects*; D001862:Bone Resorption / Q000139:chemically induced / Q000378:metabolism; D002117:Calcitriol / Q000097:blood; D000069449:Cinacalcet; D004872:Ergocalciferols / Q000009:adverse effects / Q000627:therapeutic use*; D005346:Fibroblast Growth Factors / Q000097:blood; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D054559:Hyperphosphatemia / Q000139:chemically induced / Q000378:metabolism; D006996:Hypocalcemia / Q000139:chemically induced / Q000378:metabolism; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use*; D010281:Parathyroid Hormone / Q000097:blood; D051381:Rats; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D012720:Severity of Illness Index; D013977:Tibia / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome; D014511:Uremia / Q000188:drug therapy / Q000378:metabolism
D015415:Biomarkers; D004872:Ergocalciferols; C505605:Fgf23 protein, rat; D009281:Naphthalenes; D010281:Parathyroid Hormone; D005346:Fibroblast Growth Factors; C084656:paricalcitol; D002117:Calcitriol; D000069449:Cinacalcet